{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-23-145220","form_type":"8-K","ticker":"CHRS","cik":"0001512762","company_name":"Coherus Oncology, Inc.","filed_at":"2023-05-15T23:59:59+00:00","discovered_at":"2026-05-14T18:03:39.173740+00:00","generated_at":"2026-06-15T01:04:37.667559+00:00","sec_items":["1.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Coherus reduces ATM equity offering capacity from $150M to $63.75M","bullets":["Aggregate offering price under ATM with Cowen reduced by $86.25M, from $150M to $63.75M.","Amendment No. 1 to November 2022 Sales Agreement executed on May 15, 2023.","Remaining capacity of $63.75M remains available for future at-the-market sales."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-23-145220","json":"https://secwatch.observer/filing/0001193125-23-145220.json","markdown":"https://secwatch.observer/filing/0001193125-23-145220.md","text":"https://secwatch.observer/filing/0001193125-23-145220.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1512762/000119312523145220/0001193125-23-145220-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1512762/000119312523145220/d443156d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-15T01:04:37.667559+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"cfa88f97c2e12fa07d43fe78c26aaf6e9f0b6cd6","claim":"Coherus Oncology, Inc. amended Amendment No. 1 to Sales Agreement with Cowen and Company, LLC valued at $86.25 million (effective 2023-05-15).","evidence_excerpt":"reduced the amount of shares that could be issued and sold pursuant to its “at-the-market” program (“ATM”) with Cowen and Company, LLC (“Cowen”) in an amount equal to $86.25 million.","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1512762/000119312523145220/0001193125-23-145220-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"amendment"},{"label":"Agreement","value":"atm program"},{"label":"Counterparty","value":"Cowen and Company, LLC"},{"label":"Value","value":"$86.25 million"},{"label":"Effective","value":"2023-05-15"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}